Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits.

Source:http://linkedlifedata.com/resource/pubmed/id/8324800

Download in:

View as

General Info

PMID
8324800